Cargando…
Patient and provider differences in the treatment of opioid-induced constipation: a qualitative study
BACKGROUND: Patients using opioids to treat chronic non-cancer pain often experience side effects that may affect health-related quality of life (HRQOL). These side effects include opioid-induced constipation (OIC), sedation, dizziness, and nausea. OIC can significantly affect HRQOL for patients on...
Autores principales: | Keller, Michelle S., Jusufagic, Alma, Spiegel, Brennan M. R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852732/ https://www.ncbi.nlm.nih.gov/pubmed/31718543 http://dx.doi.org/10.1186/s12876-019-1097-7 |
Ejemplares similares
-
Methylnaltrexone in the treatment of opioid-induced constipation
por: Meerveld, Beverley Greenwood-Van, et al.
Publicado: (2008) -
Constipation in Elderly Patients with Noncancer Pain: Focus on Opioid-Induced Constipation
por: Chokhavatia, Sita, et al.
Publicado: (2016) -
The Burden of Opioid-Induced Constipation: Discordance Between Patient and Health Care Provider Reports
por: LoCasale, Robert J., et al.
Publicado: (2016) -
Opioid-Induced Constipation in Advanced Cancer Patients
por: ALMouaalamy, Nabil
Publicado: (2021) -
Clinical utility of naloxegol in the treatment of opioid-induced constipation
por: Bruner, Heather C, et al.
Publicado: (2015)